Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2005
12/22/2005US20050282796 Tetracyclic azepinoindole compounds
12/22/2005US20050282782 Lewis acid mediated synthesis of cyclic esters
12/22/2005DE102004025552A1 New 2-amino-imidazo(4,5-d)pyridazin-4-one derivatives are dipeptidyl-peptidase IV inhibitors useful in the treatment of e.g. diabetes mellitus, autoimmune disease, rheumatoid arthritis, and multiple sclerosis
12/22/2005CA2727841A1 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyrido [2, 3-d] pyrimidine derivatives and related compounds
12/22/2005CA2570046A1 Substituted triazole derivatives as oxytocin antagonists
12/22/2005CA2569887A1 Pyrrolopyridine derivatives
12/22/2005CA2569111A1 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005CA2568856A1 Substituted tricyclic benzimidazoles
12/22/2005CA2568451A1 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/22/2005CA2567268A1 Thienopyridinone compounds and methods of treatment
12/22/2005CA2564499A1 Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity
12/22/2005CA2529445A1 Melanocortin-4 receptor binding compounds and methods of use thereof
12/21/2005EP1607396A1 Bicyclic inhibitors of glycogen synthase kinase 3
12/21/2005EP1606292A2 Nitrogeneous polycyclic derivatives useful as chelators of metal ions and their applications
12/21/2005EP1606291A2 Efficient synthesis of pyropheophorbide a and its dervatives
12/21/2005EP1606283A2 P38 inhibitors and methods of use thereof
12/21/2005EP1606266A2 Chemical compounds
12/21/2005EP1606255A2 Cyclic derivatives as modulators of chemokine receptor activity
12/21/2005EP1606254A1 2,4,6-phenyl substituted cyclic ketoenols
12/21/2005EP1605943A2 1-amino 1h-imidazoquinolines
12/21/2005EP1605938A2 Antibacterial agents
12/21/2005EP1463728A4 Fused cyclic modulators of nuclear hormone receptor function
12/21/2005EP1458723A4 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
12/21/2005EP1432701B1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
12/21/2005EP1377567B1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
12/21/2005EP1362039B1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
12/21/2005EP1102768B1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
12/21/2005CN1711262A Imidazo[1, 5a]pyridine derivatives and methods for treating aldosterone mediated diseases
12/21/2005CN1711261A New imidazopyrdine derivatives, its preparation method and medicine composition containing same
12/21/2005CN1711260A Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
12/21/2005CN1709892A Method for preparing total biological alkali extract of korean aconite roof and use
12/21/2005CN1232520C Salts of bicyclic N-acylated imidazo-3-amines and imidazo-5-amines
12/21/2005CN1232508C Cyclization process step in making of quinolones and phenodiazine
12/20/2005US6977305 Modified carbocyanine dyes and their conjugates
12/20/2005US6977298 Tricyclic inhibitors of poly(ADP-ribose) polymerases
12/20/2005US6977266 Pyridone derivatives having affinity for cannabinoid 2-type receptor
12/20/2005US6977264 For therapy and prophylaxis of obesity, diabetes
12/20/2005US6977263 Chemical compounds
12/20/2005US6977262 4-7-dihydropyrazolo (3,4-b)pyridine derivative useful as glycogen synthase kinase-3 beta (GSK-3 beta )- inhibitor; treats diabetes, diabetic complications and neurodegenerative diseases or as immunopotentiators
12/20/2005US6977261 Treating osteoarthritis or rheumatoid arthritis
12/20/2005US6977260 Piperidinyl prostaglandin E analogs
12/20/2005US6977255 8-Substituted 2-morpholinyl-4H-pyrido(1,2-a)pyrimidin-4-ones inhibitor of phosphoinositide (PI) 3- kinase, an enzyme that regulates platelet-adhesion (antithrombotic agent)
12/20/2005CA2338206C High affinity ligands for nociceptin receptor orl-1
12/20/2005CA2329703C Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
12/15/2005WO2005118591A1 Condensed piperidine compounds acting as adrenergic receptor antagonists useful in the treatment of prostatic hyperplasia and lower urinary symptoms
12/15/2005WO2005118590A1 Bicyclic heterocycles as hiv integrase inhibitors
12/15/2005WO2005118584A2 Saframycin analogs as therapeutic agents in the treatment of cancer
12/15/2005WO2005118583A1 2, 5-dihydro-pyrazolo`4, 3-c!quinolin-4-ones as chk-1 inhibitors
12/15/2005WO2005118582A1 Corneal perception recovery drug containing amide compound
12/15/2005WO2005118581A1 Tetrahydro-imidazo [1,5-a] pyridin derivatives as aldosterone synthase inhibitors
12/15/2005WO2005118580A2 Tricyclic compounds as inhibitors of the hypoxic signaling pathway
12/15/2005WO2005118557A2 Heterocyclic compounds and their use as aldosterone synthase inhibitors
12/15/2005WO2005118555A1 Dipeptidyl peptidase inhibitors
12/15/2005WO2005118541A2 Heterocyclic compounds and their use as aldosterone synthase inhibitors
12/15/2005WO2005118540A2 Bicyclic, nitrogen-containing heterocycles as aromatase inhibitors
12/15/2005WO2005117904A2 Phosphonate analogs of hiv integrase inhibitor compounds
12/15/2005WO2005117881A1 Process to prepare camptothecin derivatives and novel intermediate and compounds thereof
12/15/2005WO2005117876A1 Dual small molecule inhibitors of cancer and angiogenesis
12/15/2005WO2005117868A1 Tetrahydrocarboline antiviral agents
12/15/2005WO2005097768A3 Novel gamma secretase inhibitors
12/15/2005WO2005090346A3 7, 8, 9, 10- tetrahydro-imidazo [2,1-a] isoquinoline derivatives and their use as gastric acid secretion inhibitors
12/15/2005WO2005060571A3 Antiprotozoal imidazopyridine compounds
12/15/2005WO2005011597A8 Compounds and compositions as protein kinase inhibitors
12/15/2005WO2004098590A8 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
12/15/2005US20050277663 3-Aryl-3-hydroxy-and 3-aryl-3-oxopropionic acid esters as fungicides
12/15/2005US20050277662 such as: 1-(2, 4-difluorobenzyl) -N-hydroxy-3-(morpholin-4-ylmethyl)-1H-pyrrolo[2,3-c]pyridine-5-carboxamide; acquired immunodeficiency syndrome ("AIDS"), and AIDS related complex ("ARC")
12/15/2005US20050277661 Inhibitors of the HIV integrase enzyme
12/15/2005US20050277659 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as ORL1-receptor antagonists
12/15/2005US20050277654 4,5-Disubstituted-2-aryl pyrimidines
12/15/2005US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function
12/15/2005US20050277120 Novel DNA threading intercalators
12/15/2005DE102004024565A1 Verfahren zur Herstellung von α-Chloralkylpyridylketonen und/oder deren Hydrochloriden A process for preparing α-Chloralkylpyridylketonen and / or their hydrochlorides
12/15/2005DE102004022628A1 FRET-Bioassay FRET bioassay
12/15/2005CA2569266A1 Process to prepare camptothecin derivatives and novel intermediate and compounds thereof
12/15/2005CA2568622A1 Dual small molecule inhibitors of cancer and angiogenesis
12/15/2005CA2568165A1 Heterocyclic compounds and their use as aldosterone synthase inhibitors
12/15/2005CA2568164A1 Heterocyclic compounds and their use as aldosterone synthase inhibitors
12/15/2005CA2568163A1 Bicyclic, nitrogen-containing heterocycles as aromatase inhibitors
12/15/2005CA2568159A1 Tetrahydro-imidazo [1,5-a] pyridin derivatives as aldosterone synthase inhibitors
12/15/2005CA2562713A1 Phosphonate analogs of hiv integrase inhibitor compounds
12/14/2005EP1604993A1 Inhibitors
12/14/2005EP1604990A1 Phenanthroindolizidine alkaloids
12/14/2005EP1604988A1 Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
12/14/2005EP1604663A1 Zolpidem Hemitartrate Form H Solvate
12/14/2005EP1604653A1 Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder
12/14/2005EP1603913A1 Solvent-free process for the preparation of diketopyrrolopyrrole derivatives
12/14/2005EP1603912A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
12/14/2005EP1603911A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
12/14/2005EP1603910A1 Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives
12/14/2005EP1603909A2 Linear chain substituted monocyclic and bicyclic derivatives as factor xa inhibitors
12/14/2005EP1603908A1 Quinazoline derivatives as tgf-beta inhibitors
12/14/2005EP1603907A1 Substituted pyrido(1,2-a)pyrimidines and their use as nos inhibitors
12/14/2005EP1603906A2 Process for synthesising useful intermediates for the preparation of alpha v beta 3 receptor antagonists
12/14/2005EP1603900A2 Antiprotozoal imidazopyridine compounds
12/14/2005EP1603896A2 Cxcr3 antagonists
12/14/2005EP1603568A2 Isoquinoline derivatives and methods of use thereof
12/14/2005EP1603567A2 Tetracyclic benzamide derivatives and methods of use thereof
12/14/2005EP1603562A2 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
12/14/2005EP1509228B1 Derivatives of 2-(1-benzyl-1h-pyrazolo (3, 4-b)pyridine-3yl) -5-(4-pyridinyl)-4-pyrimidine amine and the use thereof as guanylate cyclase stimulators
12/14/2005EP1274430B1 Cabergoline for the treatment of fibromyalgia and chronic fatigue syndrome
1 ... 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 ... 646